Marc Scherlinger: Uncovering the Immuno-Inflammatory Functions of Platelets at EULAR 2026
Marc Scherlinger, Head of Clinic – INSERM Bettencourt, Rheumatology, Strasbourg University Hospital, shared on LinkedIn:
”Today, I had the honour of presenting an update on the role of blood platelets in autoimmune and inflammatory diseases at the European Congress of EULAR – European Alliance of Associations for Rheumatology.
For a long time, platelets were considered only as actors in hemostasis, but now appear to be major players in inflammation.
In these pathologies, they contribute in particular to the link between chronic inflammation and the increase in cardiovascular and thrombotic risk.
Our work, supported by FOREUM – Foundation for Research in Rheumatology and Inserm, sheds light on these immuno-inflammatory functions of platelets and paves the way for new therapeutic approaches to improve the management of patients with chronic inflammatory diseases, such as systemic lupus.
A big thank you to the organizers, including Professor Christophe Richez for this opportunity for scientific exchange around these clinical and translational issues.”

Stay updated with Hemostasis Today.
-
Jul 26, 2026, 01:35Moustafa Abdou: Ehlers-Danlos Syndrome – Why Collagen Matters for Hemostasis
-
Jul 26, 2026, 01:25Vrisha Shah: Exploring Transgenic Mouse Models for Pregnancy Outcomes at ISTH 2026
-
Jul 26, 2026, 01:06Christine Bork: Why Misinformation Around a Single Vitamin Postpartum is Putting Babies at Risk
-
Jul 26, 2026, 00:44A Significant Step Forward For People With Bleeding Disorders In The Dominican Republic – WFH
-
Jul 25, 2026, 18:00The Evolving Landscape of Factor Replacement Therapy – EAHAD
-
Jul 25, 2026, 17:43Heghine Khachatryan: Advancing Care for Women and Girls With Hemophilia
-
Jul 25, 2026, 17:00Revathy R Menon: A Memorable Milestone at the 39th ISBT Congress
-
Jul 25, 2026, 16:19Nicola Potere: From Scientific Exchange to Global Collaboration at ISTH 2026
-
Jul 25, 2026, 12:11Salma Abosabie: Honored to Have an Oral Presentation on Thromboinflammation at the ISTH 2026